Works by Kamei, Yoichi

Results: 9

Elranatamab in Japanese patients with relapsed/refractory multiple myeloma: results from MagnetisMM-2 and MagnetisMM-3.

Published in:

Japanese Journal of Clinical Oncology, 2024, v. 54, n. 9, p. 991, doi. 10.1093/jjco/hyae068

By:

Iida, Shinsuke;
Ito, Satoshi;
Yokoyama, Hisayuki;
Ishida, Tadao;
Nagai, Yuya;
Handa, Hiroshi;
Ito, Shigeki;
Kamei, Yoichi;
Nakamura, Masatoshi;
Suzuki, Kenshi

Publication type:

Article

Efficacy and safety of axitinib in combination with gemcitabine in advanced pancreatic cancer: subgroup analyses by region, including Japan, from the global randomized Phase III trial.

Published in:

Japanese Journal of Clinical Oncology, 2015, v. 45, n. 5, p. 439, doi. 10.1093/jjco/hyv011

By:

Tatsuya Ioka;
Takuji Okusaka;
Shinichi Ohkawa;
Narikazu Boku;
Akira Sawaki;
Yosuke Fujii;
Yoichi Kamei;
Satori Takahashi;
Katsushi Namazu;
Yoshiko Umeyama;
Bycott, Paul;
Junji Furuse

Publication type:

Article

Avelumab in Combination with Axitinib as First-Line Treatment in Patients with Advanced Hepatocellular Carcinoma: Results from the Phase 1b VEGF Liver 100 Trial.

Published in:

Liver Cancer (2235-1795), 2021, v. 10, n. 3, p. 249, doi. 10.1159/000514420

By:

Kudo, Masatoshi;
Motomura, Kenta;
Wada, Yoshiyuki;
Inaba, Yoshitaka;
Sakamoto, Yasunari;
Kurosaki, Masayuki;
Umeyama, Yoshiko;
Kamei, Yoichi;
Yoshimitsu, Junichiro;
Fujii, Yosuke;
Aizawa, Mana;
Robbins, Paul B.;
Furuse, Junji

Publication type:

Article

Avelumab plus axitinib vs sunitinib for advanced renal cell carcinoma: Japanese subgroup analysis from JAVELIN Renal 101.

Published in:

Cancer Science, 2020, v. 111, n. 3, p. 907, doi. 10.1111/cas.14294

By:

Uemura, Motohide;
Tomita, Yoshihiko;
Miyake, Hideaki;
Hatakeyama, Shingo;
Kanayama, Hiro‐omi;
Numakura, Kazuyuki;
Takagi, Toshio;
Kato, Tomoyuki;
Eto, Masatoshi;
Obara, Wataru;
Uemura, Hirotsugu;
Choueiri, Toni K.;
Motzer, Robert J.;
Fujii, Yosuke;
Kamei, Yoichi;
Umeyama, Yoshiko;
Pietro, Alessandra;
Oya, Mototsugu

Publication type:

Article

Overall survival of first-line axitinib in metastatic renal cell carcinoma: Japanese subgroup analysis from phase II study.

Published in:

Cancer Science, 2017, v. 108, n. 6, p. 1231, doi. 10.1111/cas.13232

By:

Oya, Mototsugu;
Tomita, Yoshihiko;
Fukasawa, Satoshi;
Shinohara, Nobuo;
Habuchi, Tomonori;
Rini, Brian I.;
Fujii, Yosuke;
Kamei, Yoichi;
Umeyama, Yoshiko;
Bair, Angel H.;
Uemura, Hirotsugu

Publication type:

Article

Overall survival and final efficacy and safety results from a Japanese phase II study of axitinib in cytokine-refractory metastatic renal cell carcinoma.

Published in:

Cancer Science, 2014, v. 105, n. 12, p. 1576, doi. 10.1111/cas.12546

By:

Eto, Masatoshi;
Uemura, Hirotsugu;
Tomita, Yoshihiko;
Kanayama, Hiroomi;
Shinohara, Nobuo;
Kamei, Yoichi;
Fujii, Yosuke;
Umeyama, Yoshiko;
Ozono, Seiichiro;
Naito, Seiji;
Akaza, Hideyuki

Publication type:

Article

Regulatory Elements Directing Gut Expression of the GATA6 Gene during Mouse Early Development.

Published in:

Journal of Biochemistry, 2004, v. 135, n. 2, p. 165, doi. 10.1093/jb/mvh019

By:

Ge-Hong Sun-Wada;
Kamei, Yoichi;
Wada, Yoh;
Futai, Masamitsu

Publication type:

Article

Morphology of the fibular insertion of the posterolateral corner and biceps femoris tendon.

Published in:

2017

By:

Takahashi, Hirotaka;
Tajima, Goro;
Kikuchi, Shuhei;
Yan, Jun;
Kamei, Yoichi;
Maruyama, Moritaka;
Sugawara, Atsushi;
Saigo, Takaaki;
Doita, Minoru

Publication type:

journal article

Patients with metastatic renal cell carcinoma who benefit from axitinib dose titration: analysis from a randomised, double-blind phase II study.

Published in:

2019

By:

Tomita, Yoshihiko;
Uemura, Hirotsugu;
Oya, Mototsugu;
Shinohara, Nobuo;
Habuchi, Tomonori;
Fujii, Yosuke;
Kamei, Yoichi;
Umeyama, Yoshiko;
Bair, Angel H;
Rini, Brian I

Publication type:

journal article